HPV

PGEN Earnings – Q2 2026

ArctosFXAdmin / August 6, 2026

Precigen, Inc. (Nasdaq: PGEN) reported transformative second-quarter results on August 4, 2026, driven by accelerating commercial sales of PAPZIMEOS, its […]

Analysis, Stocks

Precigen Inc. (PGEN)

ArctosFXAdmin / March 26, 2026

Precigen Inc. (NASDAQ: PGEN) is a biopharmaceutical company that focuses on advancing the next generation of gene and cell therapies

ARCTOS FX LLC is registered as a Commodity Trading Advisor (CTA) with the National Futures Association. Trading foreign exchange on margin carries a high level of risk and may not be suitable for all investors. Past performance is not indicative of future results.

HPV

PGEN Earnings – Q2 2026

Precigen Inc. (PGEN)

© 2026 Arctos FX